The immune system of pregnant women fluctuate throughout the course of the nine months carrying the child or children, this is an established fact. However, the sex of the baby as the factor has always been more of conjecture than anything else. A new study states that this isn’t the case at all and that the sex of the baby does determine the immunity of the mother.
During pregnancy, it’s normal for women to experience several changes that affect their mood, their physical attributes, and their habits. This is only to be expected since the fluctuating hormones are causing havoc in their systems. As far as their immunity goes, Ohio State University Wexner Medical Center researchers recently discovered that women carrying female fetuses tend to be more prone to inflammation, MedicalXpress reports.
According to Amanda Mitchell, one of the researchers behind the study, their research involved looking into the cases of 80 pregnant women. The tests involved measuring the levels of cytokine in their blood as well as their immune cells.
"While women didn't exhibit differences in blood cytokine levels based on fetal sex, we did find that the immune cells of women carrying female fetuses produced more pro-inflammatory cytokines when exposed to bacteria,” Mitchell said. “This means that women carrying female fetuses exhibited a heightened inflammatory response when their immune system was challenged, compared to women carrying male fetuses."
This can be a huge concern because inflammation can add stress to an already strained body, Tech Times notes. The system of a pregnant subject regularly undergoes several transitions that are normally alien. If inflammation persists, it could harm both the mother and the baby.
On that note, Mitchell added that inflammation can be easily managed by sticking to routine habits that are often encouraged by doctors. With proper exercise, a healthy diet full of leafy vegetables and fruits, and frequent meditation, inflammation can be managed.


SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss
Novartis Shares Plunge After Muscle Drug Fails Phase III Trial
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise
New Mexico Measles Outbreak Cost Reached $5.4 Million, Study Finds
China vs. NASA: The New Moon Race and What's at Stake by 2030
NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead
France Battles Mediterranean Wildfires as Heatwave Fuels Fire Risk
Trump Signs Order to Cut Routine Childhood Vaccines
Neuralink Expands Brain Implant Trials with 12 Global Patients
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
SpaceX Delays Starship V3 Launch Ahead of Potential Record IPO
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 



